Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 26 Jun 2024 |
| Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate | 17 Jun 2024 |
| Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine | 31 May 2024 |
| Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise | 22 May 2024 |
| Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program | 21 May 2024 |
| EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic | 21 May 2024 |